Key Metrics
CiteScore 

1
Impact Factor 

< 5
SJR 

Q4Rheumatology

Recommended pre-submission checks
Powered by 

Acta Reumatologica Portuguesa Journal Specifications
Indexed in the following public directories
Scopus
Web of Science
| Overview | |
| Publisher | Sociedade Portuguesa de Reumatologia |
| Language | Portuguese,English |
| Frequency | Quarterly |
| General Details | |
| Language | Portuguese,English |
| Frequency | Quarterly |
| Publication Start Year | 1973 |
View less
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers in Acta Reumatologica Portuguesa
Correspondence on: Real-world safety data of first-line drugs for rheumatoid arthritis: insights from the Portuguese Reuma.pt database.
- 12 Jun 2026
- ARP rheumatology
Correspondence on: Serum caspase-1 is correlated with vasculitis activity at diagnosis and associated with all-cause mortality in patients with antineutrophil cytoplasmic antibody-associated vasculitis.
- 6 Feb 2026
- ARP rheumatology
Points to consider for patient education provided by nurses on methotrexate use. A European consensus initiative.
- 5 Feb 2026
- ARP rheumatology
Large vessel vasculitis: syphilitic aortitis as a reversible mimicker.
- 1 Feb 2026
- ARP rheumatology
Emapalumab's role in a severe and treatment-resistant paediatric macrophage activation syndrome.
- 1 Feb 2026
- ARP rheumatology
Relapsing polychondritis in a patient treated with Dupilumab.
- 1 Feb 2026
- ARP rheumatology
Correspondence on: Real-world safety data of first-line drugs for rheumatoid arthritis: insights from the Portuguese Reuma.pt database.
- 12 Jun 2026
- ARP rheumatology
Correspondence on: Serum caspase-1 is correlated with vasculitis activity at diagnosis and associated with all-cause mortality in patients with antineutrophil cytoplasmic antibody-associated vasculitis.
- 6 Feb 2026
- ARP rheumatology
Points to consider for patient education provided by nurses on methotrexate use. A European consensus initiative.
- 5 Feb 2026
- ARP rheumatology
Large vessel vasculitis: syphilitic aortitis as a reversible mimicker.
- 1 Feb 2026
- ARP rheumatology
Emapalumab's role in a severe and treatment-resistant paediatric macrophage activation syndrome.
- 1 Feb 2026
- ARP rheumatology
Relapsing polychondritis in a patient treated with Dupilumab.
- 1 Feb 2026
- ARP rheumatology